SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-17-358755
Filing Date
2017-12-01
Accepted
2017-12-01 14:52:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 S-3/A d473269ds3a.htm S-3/A 62589
2 EX-5.1 d473269dex51.htm EX-5.1 22578
  Complete submission text file 0001193125-17-358755.txt   86110
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-221491 | Film No.: 171233920
SIC: 2836 Biological Products, (No Diagnostic Substances)